Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zuzana Pikalova

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 11, 2007
Immunophenotyping--a tool for the differential diagnostics of lymphadenomegalyZuzana Pikalova, Tomas Szotkowski, Karel Indrak
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 20, 2017
Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatmentMartin Cernan, Tomas Szotkowski, Zuzana Pikalova
Leukemia & Lymphoma|January 19, 2010
Gain of chromosome 2p in chronic lymphocytic leukemia: significant heterogeneity and a new recurrent dicentric rearrangementMarie Jarosova, Helena Urbankova, Radek Plachy, et al.
European Journal of Haematology|May 5, 2017
CD38-negative relapse in multiple myeloma after daratumumab-based chemotherapyJiri Minarik, Martin Novak, Patrik Flodr, et al.
International Journal of Hematology|October 12, 2014
Comparison of reduced conditionings combining fludarabine with melphalan or 3-day busulfan in patients allografted for myeloid neoplasmsLudek Raida, Zuzana Rusinakova, Edgar Faber, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 13, 2013
Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemiaLenka Humplikova, Sona Kollinerova, Tomas Papajik, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 18, 2012
Array-based karyotyping in chronic lymphocytic leukemia (CLL) detects new unbalanced abnormalities that escape conventional cytogenetics and CLL FISH panelHelena Urbankova, Tomas Papajik, Radek Plachy, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 11, 2007
Spontaneous splenic rupture in two patients with hematologic malignancyTomas Szotkowski, Romana Szotkowska, Zuzana Pikalova, et al.
Journal of Clinical Apheresis|March 17, 2026
Twenty Years of Therapeutic Leukocytapheresis in Newly Diagnosed Acute Myeloid Leukemia: Insights From A Single CenterVojtech Latal, Ivana Skoumalova, Miroslava Palova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 24, 2009
Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remissionTomas Papajik, Zuzana Pikalova, Ludek Raida, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 11, 2007
Immunophenotyping--a tool for the differential diagnostics of lymphadenomegalyZuzana Pikalova, Tomas Szotkowski, Karel Indrak
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 20, 2017
Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatmentMartin Cernan, Tomas Szotkowski, Zuzana Pikalova
Leukemia & Lymphoma|January 19, 2010
Gain of chromosome 2p in chronic lymphocytic leukemia: significant heterogeneity and a new recurrent dicentric rearrangementMarie Jarosova, Helena Urbankova, Radek Plachy, et al.
European Journal of Haematology|May 5, 2017
CD38-negative relapse in multiple myeloma after daratumumab-based chemotherapyJiri Minarik, Martin Novak, Patrik Flodr, et al.
International Journal of Hematology|October 12, 2014
Comparison of reduced conditionings combining fludarabine with melphalan or 3-day busulfan in patients allografted for myeloid neoplasmsLudek Raida, Zuzana Rusinakova, Edgar Faber, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 13, 2013
Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemiaLenka Humplikova, Sona Kollinerova, Tomas Papajik, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 18, 2012
Array-based karyotyping in chronic lymphocytic leukemia (CLL) detects new unbalanced abnormalities that escape conventional cytogenetics and CLL FISH panelHelena Urbankova, Tomas Papajik, Radek Plachy, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 11, 2007
Spontaneous splenic rupture in two patients with hematologic malignancyTomas Szotkowski, Romana Szotkowska, Zuzana Pikalova, et al.
Journal of Clinical Apheresis|March 17, 2026
Twenty Years of Therapeutic Leukocytapheresis in Newly Diagnosed Acute Myeloid Leukemia: Insights From A Single CenterVojtech Latal, Ivana Skoumalova, Miroslava Palova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|October 24, 2009
Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remissionTomas Papajik, Zuzana Pikalova, Ludek Raida, et al.
Pageof 2